Evidence Generation – on the road to standardisation along the life-cycle of health technology

The EUnetHTA JA 2 activities addressed all relevant phases of the Life Cycle of health technology development including the pre-licensing phase (in early scientific advice (Early Dialogues) and market entry through the early assessments of the evidence in rapid REAs and additional data and evidence collection EUnetHTA Early Dialogues aim at helping pharmaceutical and MedTech companies […]